abagovomab 41
abciximab 36
abituzumab 24
abrilumab 24
actoxumab 21
adalimumab 22
aducanumab 15
afasevikumab 21
alacizumab_pegol 15
alemtuzumab 36
alirocumab 27
amatuximab 48
andecaliximab 25
anifrolumab 25
anrukinzumab 24
aprutumab 22
aprutumab_ixadotin 22
arcitumomab 29
ascrinvacumab 11
atezolizumab 17
atinumab 17
avelumab 16
basiliximab 42
bavituximab 46
begelomab 34
benralizumab 32
bevacizumab_beta 27
bezlotoxumab 21
bimagrumab 22
bleselumab 24
blinatumomab 41
blosozumab 34
bococizumab 22
brazikumab 18
brentuximab_vedotin 41
briakinumab 20
brodalumab 19
brolucizumab 31
brontictuzumab 29
burosumab 23
cabiralizumab 30
camrelizumab 16
canakinumab 28
cantuzumab_ravtansin 51
carlumab 18
carotuximab 32
cergutuzumab_amunaleukin2 31
cergutuzumab_amunaleukin 31
certolizumab_pegol 27
cetiximab 50
citatuzumab_bogatox 30
cixutumumab 33
clivatuzumab_tetraxetan 30
codrituzumab 35
conatumumab 18
concizumab 33
crenezumab 25
crizanlizumab 30
crotedumab 23
dacetuzumab 26
daclizumab 23
dalotuzumab 44
dapirolizumab_pegol 29
daratumumab 14
dectrekumab 11
demcizumab 31
denosumab 11
depatuxizumab 32
depatuxizumab_mafodotin 32
dezamizumab 26
dinutuximab 42
diridavumab 32
domagrozumab 18
drozitumab 24
duligotuzumab 21
durvalumab 14
dusigitumab 28
efalizumab 36
efungumab 34
eldelumab 18
elezanumab 25
elgemtumab 14
elotuzumab 20
emactuzumab 24
emapalumab 28
emibetuzumab 26
enavatuzumab 26
enfortumab_vedotin 15
enoblituzumab 22
enokizumab 27
enoticumab 20
ensituximab 44
eptinezumab 20
erenumab 28
etaracizumab 18
etrolizumab 25
evinacumab 23
evolocumab 24
farletuzumab 16
fasinumab 27
fezakinumab 28
fibatuzumab 19
ficlatuzumab 29
firivumab 37
flanvotumab 23
fletikumab 31
foralumab 16
foravirumab 16
fremanezumab 31
fresolimumab 20
fulranumab 24
futuximab 39
galcanezumab 25
ganitumab 34
gantenerumab 15
gemetuzumab 36
gemtuzumab2 28
gemtuzumab 34
gevokizumab 30
girentuximab 37
glembatumumab 23
glembatumumab_vedotin 23
guselkumab 27
ibalizumab 33
ibritumomab 46
icrucumab 13
idarucizumab 47
ifabotuzumab 19
imalumab 19
imgatuzumab 25
inclacumab 21
indatuximab_ravtansin 41
indusatumab 23
inebilizumab 34
intetumumab 18
iodine_girentuximab 31
ipilimumab 7
iratumumab 18
isatuximab 42
itolizumab 30
ixekizumab 38
labetuzumab_govitecan 31
lambrolizumab 31
lampalizumab 32
lanadelumab 19
landogrozumab 19
laprituximab 32
lebrikizumab 43
lendalizumab 28
lenzilumab 21
lifastuzumab_vedotin 26
ligelizumab 25
lilotomab 48
lirilumab 25
lodelcizumab 22
lokivetmab 28
lorvotuzumab_mertansin 29
lucatumumab 31
lumretuzumab 25
lupartumab 21
lutikizumab 23
margetuximab 45
milatuzumab 46
mirvetuximab 43
mirvetuximab_soravtansin 43
modotuximab 46
mogamulizumab 36
monalizumab 24
motavizumab 42
moxetumomab_pasudotox 34
namilumab 28
naratuximab 35
naratuximab_emtansin 35
narnatumab 20
navicixizumab2 33
navicixizumab 32
navivumab 41
necitumumab 12
nemolizumab 33
nesvacumab 18
nivolumab 15
obiltoxaximab 29
obinutuzumab 39
ocaratuzumab 29
ofatumumab 20
olaratumab 24
olokizumab 29
omalizumab 22
onartuzumab 25
ontuxizumab 37
opicinumab 15
orticumab 16
otelixizumab 41
oxelumab 14
ozanezumab 38
pamrevlumab 13
panobacumab 32
parsatuzumab 30
pasotuxizumab 23
pateclizumab 22
patritumab 31
pembrolizumab 31
perakizumab 25
pidilizumab 24
pinatuzumab_vedotin 19
plozalizumab 37
pogalizumab 27
polatuzumab_vedotin 24
ponezumab 42
prezalumab 16
pritoxaximab 47
quilizumab 23
racotumomab 38
radretumab 16
ralpancizumab 25
ramucirumab 14
ranevetmab 34
ranibizumab 27
refanezumab 31
remtolumab 22
rilotumumab 26
rinucumab 24
risankizumab 39
rituximab 33
rivabazumab 24
robatumumab 20
roledumab 37
romosozumab 27
rontalizumab 25
rosmantuzumab 31
rozanolixizumab 25
sacituzumab 35
sacituzumab_govitecan 35
samalizumab 32
sapelizumab 28
sarilumab 19
secukinumab 19
seribantumab 18
setoxaximab 52
sifalimumab 17
siltuximab 29
simtuzumab 31
sirukumab 15
solanezumab 27
solitomab 37
stamulumab 24
suptavumab 28
suvizumab 26
tabalumab 19
tadocizumab 22
tamtuvetmab 40
tanezumab 29
tarextumab 13
tavolixizumab 19
telisotuzumab 34
teplizumab 27
tesidolumab 24
tezepelumab 27
tigatuzumab 18
tildrakizumab 26
timolumab 17
tisotumab 16
tosatoxumab 46
tositumomab 45
tralokinumab 34
trastuzumab 25
tregalizumab 34
trevogrumab 16
ublituximab 39
urelumab 28
ustekinumab 30
utomilumab 31
vadastuximab 31
vadastuximab_talirin 31
vandortuzumab_vedotin 24
vantictumab 22
vanucizumab2 27
vanucizumab 35
varlilumab 18
vatelizumab 26
vedolizumab 33
veltuzumab 23
vesencumab 13
vorsetuzumab 30
vorsetuzumab_mafodotin 30
vunakizumab 40
xentuzumab 22
zatuximab 46
